This article was originally published here
Rev Fac Cien Med Univ Nac Cordoba. 2022 Mar 7;79(1):65-68. doi: 10.31053/1853.0605.v79.n1.29337.
INTRODUCTION: The role of the use of Extracorporeal Membrane Oxygenation (ECMO) in patients with coronavirus disease (COVID-19) is under discussion. Whereas in patients with Acute Respiratory Distress Syndrome (ARDS) the ECMO is a usual rescue measure used to optimize the oxygenation as a bridge to pulmonary rehabilitation, in patients that have refractory hypoxemic respiratory failure with recovery potential, the use of ECMO could also be beneficial.
OBJECTIVE: The purpose of this work is to report the first case of COVID-19 that required ECMO in Argentina, with a good response.
METHODOLOGY: We describe the first case of COVID-19 that required ECMO in Argentina, in a patient without comorbidities, with good clinical results.
RESULTS: The use of ECMO in the reported case provided a substantial benefit in oxygenation, acting as a bridge to lung recovery, without presenting complications associated with its application.
CONCLUSION: In critically ill patients with refractory hypoxemia, but with high recovery potential, ECMO support can be considered as a rescue measure.